These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Clinical trial of the new oral hypoglycaemic agent BZ 55. HUNT JA; OAKLEY W; LAWRENCE RD Br Med J; 1956 Aug; 2(4990):445-8. PubMed ID: 13342509 [No Abstract] [Full Text] [Related]
44. [Annual movement]. DEROT M; PIGNARD P; RATHERY M Gaz Med Fr; 1957 Mar; 64(6):567-78. PubMed ID: 13427962 [No Abstract] [Full Text] [Related]
45. Recent studies relative to the treatment of diabetes; special reference to new oral antidiabetic drugs. WILLIAMS RH; HENLEY ED AMA Arch Intern Med; 1957 Apr; 99(4):501-18. PubMed ID: 13410156 [No Abstract] [Full Text] [Related]
46. Some clinical experiences with the arylsulfonylureas in the management of diabetes mellitus. ERK V; HAAR H; MCGAVACK TH; SEEGERS W Metabolism; 1956 Nov; 5(6 Part 2):919-32. PubMed ID: 13378061 [No Abstract] [Full Text] [Related]
47. [Oral therapy of diabetes]. MELLINGHOFF CH Med Klin; 1956 Sep; 51(36):1497-502. PubMed ID: 13358558 [No Abstract] [Full Text] [Related]
48. The use of orinase in diabetes. BEASER SB Metabolism; 1956 Nov; 5(6 Part 2):933-9. PubMed ID: 13378062 [No Abstract] [Full Text] [Related]
49. Ineffectiveness of sulfonylureas in alloxan diabetic rats. MIRSKY IA; PERISUTTI G; JINKS R Proc Soc Exp Biol Med; 1956 Mar; 91(3):475-7. PubMed ID: 13322970 [No Abstract] [Full Text] [Related]
50. Clinical experiences with carbutamide, an orally given hypoglycemic agent; preliminary report. RIDOLFO AS; KIRTLEY WR J Am Med Assoc; 1956 Apr; 160(15):1285-8. PubMed ID: 13306540 [No Abstract] [Full Text] [Related]
51. [Examination of steroids in therapy with N'-sulfanilyl-N2-N-butylcarbamid (nadisan)]. RAUSCH-STROOMANN JG; SAUER H Klin Wochenschr; 1956 Jul; 34(25-26):707-8. PubMed ID: 13347046 [No Abstract] [Full Text] [Related]
52. Blood glutathione in mild diabetes mellitus before treatment and during sulfonylurea-induced hypoglycemia. SELTZER HS Proc Soc Exp Biol Med; 1957 May; 95(1):74-6. PubMed ID: 13431994 [No Abstract] [Full Text] [Related]
53. Metabolic studies with the arylsulfonylureas. KUHL WJ Metabolism; 1956 Nov; 5(6 Part 2):953-63. PubMed ID: 13378065 [No Abstract] [Full Text] [Related]
55. [BZ 55 of D 860 as oral antidiabetic]. MEHNERT B; MEHNERT H Munch Med Wochenschr; 1956 Sep; 98(39):1325-8. PubMed ID: 13378442 [No Abstract] [Full Text] [Related]
56. [Oral treatment of diabetes mellitus with D-860, a new hypoglycemic but not sulfonamidic drug; clinical study of 90 cases]. INTROZZI P; MARIGO S Prog Med (Napoli); 1956 Sep; 12(17):513-27. PubMed ID: 13379550 [No Abstract] [Full Text] [Related]
57. Clinical experience with carbutamide and tolbutamide. COHN C; HEINEMAN A; LEVINE R; WEINSTEIN M Metabolism; 1956 Nov; 5(6 Part 2):972-7. PubMed ID: 13378067 [No Abstract] [Full Text] [Related]
58. Diabetes mellitus. BERNHARD H Indian J Med Sci; 1957 Feb; 11(2):59-63. PubMed ID: 13428303 [No Abstract] [Full Text] [Related]
59. Clinical experience and experimental studies with tolbutamide. CRAIG JW; MILLER M Diabetes; 1957; 6(1):77-9; discussion, 85-90. PubMed ID: 13397433 [No Abstract] [Full Text] [Related]
60. Intrapancreatic infusions of the sulfonylureas. COLWELL AR; COLWELL JA Diabetes; 1957; 6(1):60; discussion, 62. PubMed ID: 13397425 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]